New immunotherapy shows promise in slowing deadly brain cancer
NCT ID NCT04485949
First seen Sep 30, 2025 · Last updated May 07, 2026 · Updated 30 times
Summary
This study tests an experimental immunotherapy called IGV-001 in people newly diagnosed with glioblastoma, an aggressive brain cancer. The treatment uses a patient's own cells to target the cancer and is compared to a placebo. The goal is to see if it can slow tumor growth and help people live longer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University Medical Center
New York, New York, 10032, United States
-
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, 03756, United States
-
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
New York, New York, 10021, United States
-
Henry Ford Health System
Detroit, Michigan, 48202, United States
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
-
Jersey Shore University Medical Center
Neptune City, New Jersey, 07753, United States
-
John Theurer Cancer Center At Hackensack UMC
Hackensack, New Jersey, 07601, United States
-
Lenox Hill Hospital
New York, New York, 10075, United States
-
Mayo Clinic - Jacksonville
Jacksonville, Florida, 32224, United States
-
Montefiore Medical Center
The Bronx, New York, 10467, United States
-
Northwell Health at North Shore University Hospital
Manhasset, New York, 11030, United States
-
Rhode Island Hospital
Providence, Rhode Island, 02903, United States
-
The Ohio State University (OSU) Wexner Medical Center
Columbus, Ohio, 43201, United States
-
The Pennsylvania State University (Penn State) Milton S. Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
-
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
-
Tufts Medical Center
Boston, Massachusetts, 02111, United States
-
UC Health
Cincinnati, Ohio, 45229, United States
-
University of North Carolina (UNC) - Chapel Hill
Chapel Hill, North Carolina, 27599, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19130, United States
-
University of Wisconsin - Madison
Madison, Wisconsin, 53705, United States
-
Weill Cornell Medicine
New York, New York, 10065, United States
-
West Virginia University
Morgantown, West Virginia, 26506, United States
-
Westchester Medical Center
Valhalla, New York, 10595, United States
Conditions
Explore the condition pages connected to this study.